C204-0169 Screening compound: N-[4-METHYL-2-(MORPHOLIN-4-YL)QUINOLIN-6-YL]-4-OXO-4-{4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1-YL}BUTANAMIDE

C204-0169 Screening compound: N-[4-METHYL-2-(MORPHOLIN-4-YL)QUINOLIN-6-YL]-4-OXO-4-{4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1-YL}BUTANAMIDE
C204-0169 Screening compound: N-[4-METHYL-2-(MORPHOLIN-4-YL)QUINOLIN-6-YL]-4-OXO-4-{4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1-YL}BUTANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound C204-0169
N-[4-METHYL-2-(MORPHOLIN-4-YL)QUINOLIN-6-YL]-4-OXO-4-{4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1-YL}BUTANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C204-0169

Molecular Formula

C29H32F3N5O3 (C29 H32 F3 N5 O3)

Compound Name

N-[4-METHYL-2-(MORPHOLIN-4-YL)QUINOLIN-6-YL]-4-OXO-4-{4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1-YL}BUTANAMIDE

IUPAC name

n/a

SMILES

Cc1c(cc(cc2)NC(CCC(N(CC3)CCN3c3cccc(C(F)(F)F)c3)=O)=O)c2nc(N2CCOCC2)c1

InChI

InChI=1S/C29H32F3N5O3/c1-20-17-26(36-13-15-40-16-14-36)34-25-6-5-22(19-24(20)25)33-27(38)7-8-28(39)37-11-9-35(10-12-37)23-4-2-3-21(18-23)29(30,31)32/h2-6,17-19H,7-16H2,1H3,(H,33,38)

InChI Key

PXTXFTXGAHXXQE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14731981

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

555.6

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.357

Distribution Coefficient, logD

4.357

Water Solubility, LogSw

-4.33

Polar Surface Area

61.924

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

4.21

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

C204-0169 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

PI3K-Targeted Library (17255 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C204-0169 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C204-0169?
Check Price and Availability of C204-0169, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C204-0169 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C204-0169
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C204-0169
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C204-0169 available by request